Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs

ABSTRACT Increasing evidence has confirmed the existence of cancer stem cells (CSCs) in both hematological malignancies and solid tumors. However, the origin of CSCs is still uncertain, and few agents have been capable of eliminating CSCs till now. The aim of this study was to investigate whether bulk pancreatic cancer cells could convert into CSCs under certain conditions and explore whether metformin and curcumin can kill pancreatic CSCs. Aspc1, Bxpc3 and Panc1 pancreatic cancer cells were cultured in stem cell culture medium (serum-free Dulbecco's modified Eagle medium/Nutrient Mixture F-12 containing basic fibroblast growth factor, epidermal growth factor, B27 and insulin) for 5 days and it was found that all the pancreatic cancer cells aggregated into spheres and expressed pancreatic cancer stem cell surface markers. Then characteristics of Panc1 sphere cells were analyzed and cytotoxicity assays were performed. The results show that Panc1 sphere cells exhibited CSC characteristics and were more resistant to conventional chemotherapy and more sensitive to metformin and curcumin than their parent cells. These findings suggested that bulk pancreatic cancer cells could acquire CSC characteristics under certain conditions, which may support the “yin-yang” model of CSCs (interconversion between bulk cancer cells and CSCs). These results also showed that metformin and curcumin could be candidate drugs for targeting pancreatic CSCs.

[1]  C. Albigès-Rizo,et al.  Microenvironment, tumor cell plasticity, and cancer , 2015, Current opinion in oncology.

[2]  J. Vadgama,et al.  Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling. , 2015, Anticancer research.

[3]  Bo Yang,et al.  Stem cell characteristics of dormant cells and cisplatin‑induced effects on the stemness of epithelial ovarian cancer cells. , 2014, Molecular medicine reports.

[4]  Hongliu Sun,et al.  Survival improvement in patients with pancreatic cancer by decade: A period analysis of the SEER database, 1981–2010 , 2014, Scientific Reports.

[5]  Johan Lindberg,et al.  Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo , 2014, Breast Cancer Research.

[6]  P. Hahnfeldt,et al.  A Proposed Quantitative Index for Assessing the Potential Contribution of Reprogramming to Cancer Stem Cell Kinetics , 2014, Stem cells international.

[7]  Chang-Shin Park,et al.  Response of Breast Cancer Cells and Cancer Stem Cells to Metformin and Hyperthermia Alone or Combined , 2014, PloS one.

[8]  Meiping Guan,et al.  Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients , 2013, PloS one.

[9]  L. Wen,et al.  Curcumin enhances the effectiveness of cisplatin by suppressing CD133+ cancer stem cells in laryngeal carcinoma treatment , 2013, Experimental and therapeutic medicine.

[10]  P. Cui,et al.  Low Concentrations of Metformin Selectively Inhibit CD133+ Cell Proliferation in Pancreatic Cancer and Have Anticancer Action , 2013, PloS one.

[11]  Shanrong Liu,et al.  Cancer stem cells: a shifting subpopulation of cells with stemness? , 2013, Medical hypotheses.

[12]  G. Sambuceti,et al.  Metformin selectively affects human glioblastoma tumor-initiating cell viability , 2013, Cell Cycle.

[13]  S. Kleffel,et al.  Tumor dormancy and cancer stem cells: two sides of the same coin? , 2013, Advances in experimental medicine and biology.

[14]  R. Buckanovich,et al.  Metformin targets ovarian cancer stem cells in vitro and in vivo. , 2012, Gynecologic oncology.

[15]  Li Lin,et al.  Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030 , 2011, British Journal of Cancer.

[16]  Paul A. Wiggins,et al.  Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state , 2011, Proceedings of the National Academy of Sciences.

[17]  M. Todaro,et al.  Colorectal Cancer Stem Cells and Cell Death , 2011, Cancers.

[18]  C. Giordano,et al.  Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells , 2010, Bioscience reports.

[19]  R. Naftalovich,et al.  Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: towards targeting of cancer stem cells with phytochemicals. , 2010, Cancer letters.

[20]  Xiaobing Fu,et al.  Dedifferentiation derived cells exhibit phenotypic and functional characteristics of epidermal stem cells , 2009, Journal of cellular and molecular medicine.

[21]  G. Dontu,et al.  Targeting breast stem cells with the cancer preventive compounds curcumin and piperine , 2010, Breast Cancer Research and Treatment.

[22]  Kevin Struhl,et al.  Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. , 2009, Cancer research.

[23]  O. Er,et al.  Cancer Stem Cells in Solid Tumors , 2009, Oncology Research and Treatment.

[24]  S. Krauss,et al.  Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma , 2009, Clinical & Experimental Metastasis.

[25]  K. Rowan.  Are cancer stem cells real? After four decades, debate still simmers. , 2009, Journal of the National Cancer Institute.

[26]  Peng Huang,et al.  Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma. , 2008, World journal of gastroenterology.

[27]  Jiangbing Zhou,et al.  Cancer stem cells: Models, mechanisms and implications for improved treatment , 2008, Cell cycle.

[28]  Xiaobing Fu,et al.  In vivo dedifferentiation of human epidermal cells , 2007, Cell biology international.

[29]  D. Wion,et al.  Fluctuation of the SP/non‐SP phenotype in the C6 glioma cell line , 2007, FEBS letters.

[30]  H. Namba,et al.  Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. , 2007, Endocrinology.

[31]  P. Dalerba,et al.  Identification of pancreatic cancer stem cells. , 2006, Cancer research.

[32]  Peter T Masiakos,et al.  Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Tetsuhiro Chiba,et al.  Side population purified from hepatocellular carcinoma cells harbors cancer stem cell–like properties , 2006, Hepatology.

[34]  M. Goodell,et al.  A distinct "side population" of cells with high drug efflux capacity in human tumor cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  T. Kondo,et al.  Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[37]  Xiaobing Fu,et al.  Dedifferentiation of epidermal cells to stem cells in vivo , 2001, The Lancet.

[38]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[39]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.